Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5669
pubmed:dateCreated
2004-4-16
pubmed:databankReference
pubmed:abstractText
Mitochondrial dysfunction is a hallmark of beta-amyloid (Abeta)-induced neuronal toxicity in Alzheimer's disease (AD). Here, we demonstrate that Abeta-binding alcohol dehydrogenase (ABAD) is a direct molecular link from Abeta to mitochondrial toxicity. Abeta interacts with ABAD in the mitochondria of AD patients and transgenic mice. The crystal structure of Abeta-bound ABAD shows substantial deformation of the active site that prevents nicotinamide adenine dinucleotide (NAD) binding. An ABAD peptide specifically inhibits ABAD-Abeta interaction and suppresses Abeta-induced apoptosis and free-radical generation in neurons. Transgenic mice overexpressing ABAD in an Abeta-rich environment manifest exaggerated neuronal oxidative stress and impaired memory. These data suggest that the ABAD-Abeta interaction may be a therapeutic target in AD.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1095-9203
pubmed:author
pubmed:issnType
Electronic
pubmed:day
16
pubmed:volume
304
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
448-52
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:15087549-3-Hydroxyacyl CoA Dehydrogenases, pubmed-meshheading:15087549-Aged, pubmed-meshheading:15087549-Aged, 80 and over, pubmed-meshheading:15087549-Alzheimer Disease, pubmed-meshheading:15087549-Amino Acid Sequence, pubmed-meshheading:15087549-Amyloid beta-Peptides, pubmed-meshheading:15087549-Animals, pubmed-meshheading:15087549-Binding Sites, pubmed-meshheading:15087549-Brain, pubmed-meshheading:15087549-Brain Chemistry, pubmed-meshheading:15087549-Carrier Proteins, pubmed-meshheading:15087549-Cells, Cultured, pubmed-meshheading:15087549-Cerebral Cortex, pubmed-meshheading:15087549-Crystallization, pubmed-meshheading:15087549-DNA Fragmentation, pubmed-meshheading:15087549-Hippocampus, pubmed-meshheading:15087549-Humans, pubmed-meshheading:15087549-Learning, pubmed-meshheading:15087549-Memory, pubmed-meshheading:15087549-Mice, pubmed-meshheading:15087549-Mice, Transgenic, pubmed-meshheading:15087549-Microscopy, Confocal, pubmed-meshheading:15087549-Microscopy, Immunoelectron, pubmed-meshheading:15087549-Mitochondria, pubmed-meshheading:15087549-Models, Molecular, pubmed-meshheading:15087549-Molecular Sequence Data, pubmed-meshheading:15087549-Mutation, pubmed-meshheading:15087549-NAD, pubmed-meshheading:15087549-Neurons, pubmed-meshheading:15087549-Protein Binding, pubmed-meshheading:15087549-Protein Conformation, pubmed-meshheading:15087549-Reactive Oxygen Species
pubmed:year
2004
pubmed:articleTitle
ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease.
pubmed:affiliation
Center for Reproductive Sciences and Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, 630 West 168th Street, New York, NY 10032, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't